Stock Events

Stock Events

Noveris Health Sciences 

€0
0
+€0+0% Today

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 0NF1.MU. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Compass Pathways
CMPS
Mkt Cap746.47M
Compass Pathways focuses on psilocybin therapy for mental health disorders, directly competing in the psychedelic medicine space with Mydecine Innovations.
AtaiBeckley
ATAI
Mkt Cap1.38B
ATAI Life Sciences is a biotech company working on mental health treatments using psychedelics, overlapping with Mydecine's focus areas.
GH Research
GHRS
Mkt Cap903.77M
GH Research focuses on developing 5-MeO-DMT therapies for depression, competing in the psychedelic treatment market.
Revive Therapeutics
RVVTF
Mkt Cap12.2M
Revive Therapeutics is exploring the use of psychedelics for medical treatments, including areas Mydecine Innovations is involved in.
Nuveen Municipal Income
NUMI
Mkt Cap0
Numinus Wellness is engaged in psychedelic production and therapy, directly competing with Mydecine's business model.
TripAdvisor
TRIP
Mkt Cap1.27B
Red Light Holland is involved in the production and sale of recreational truffles, indirectly competing by promoting psychedelic acceptance.

About

Mydecine Innovations Group Inc., a biotechnology company, engages in the development and commercialization of psilocybin products for treating mental health problems. The company primarily focuses on treating smoking cessation. Its lead product drug candidates include MYCO-001, MYCO-002, MYCO003, and MYCO-004. Mydecine Innovations Group Inc. has a partnership with Applied Pharmaceutical Innovation for pharmaceutical drug discovery, research, and development on empathogenic and entactogenic compounds. The company was formerly known as NewLeaf Brands Inc. and changed its name to Mydecine Innovations Group Inc. in June 2020. Mydecine Innovations Group Inc. was incorporated in 2013 and is headquartered in Vancouver, Canada.
Show more...
CEO
Mr. David Joshua Bartch
Employees
3
Country
Canada
ISIN
CA66990B1085

Listings

STU
DE
0NF1.STU
MU
DE
0NF1.MU
OTC Link
US
MYCOF
CN
CA
NVRS.CN

0 Comments

Share your thoughts

FAQ

What is Noveris Health Sciences stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Noveris Health Sciences stocks are traded under the ticker 0NF1.MU.
How many employees does Noveris Health Sciences have?▼
As of April 11, 2026, the company has 3 employees.
In which sector is Noveris Health Sciences located?▼
Noveris Health Sciences operates in the Health & Wellness sector.
When did Noveris Health Sciences complete a stock split?▼
Noveris Health Sciences has not had any recent stock splits.
Where is Noveris Health Sciences headquartered?▼
Noveris Health Sciences is headquartered in Vancouver, Canada.